Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to further advance its biomarker discovery platform.

With this distribution partnership, Witec AG and Scailyte address a long-standing need for a more efficient, cost-effective and insightful single-cell data analysis solution within the Swiss life sciences industry.